**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 61790-53-2 |Kieselguhr | >99 | unlisted |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: None Listed.
Risk Phrases: None Listed.
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Not available.
Potential Health Effects
Eye:
Dust may cause mechanical irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract.
Inhalation:
Contains crystalline silica which may lead to respiratory
abnormalities and silicosis. Causes irritation of the mucous
membrane and upper respiratory tract.
Chronic:
Chronic exposure may cause lung damage. May cause
silicosis-disabling pulmonary fibrosis characterized by fibrotic
changes and miliary nodules in the lungs, dry cough, shortness of
breath, emphysema, decreased chest expansion and increased
susceptibility to tuberculosis.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid if irritation or symptoms occur.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively. Persons with pre-existing
upper respiratory and lung disease may be at increased risk from
exposure to this product.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
For small fires, use dry chemical, carbon dioxide, water spray or
alcohol-resistant foam. Use extinguishing media most appropriate for
the surrounding fire.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Minimize dust generation and accumulation. Avoid breathing dust,
vapor, mist, or gas. Avoid contact with skin and eyes. Avoid
ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 61790-53-2:
United Kingdom, WEL - TWA: 1.2 mg/m3 TWA (respirable dust)
United Kingdom, WEL - STEL: 3.6 mg/m3 STEL (respirable dust)
Belgium - TWA: 3 mg/m3 VLE (respirable fraction); 10 mg/m3 VLE
(inhalable fraction)
Germany: 4 mg/m3 TWA (inhalable fraction)
Malaysia: 10 mg/m3 TWA (particulate matter containing no asbestos
<1% crystalline sili
Spain: 10 mg/m3 VLA-ED (inhalable fraction, this value is for the
particulated matter t
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: slightly gray
Odor: odorless
pH: 9-10
Vapor Pressure: 10 mm Hg @ 1710
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: insoluble
Specific Gravity/Density:
Molecular Formula:
Molecular Weight:
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Hydrogen fluoride, strong acids.
Hazardous Decomposition Products:
Oxides of silicon.
Hazardous Polymerization: Will not occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 61790-53-2: VV7311000
LD50/LC50:
Not available.
Carcinogenicity:
Kieselguhr -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Ecotoxicity:
Fish: Carp: LC50 > 10000 mg/L; 72 Hr; UnspecifiedNo information
available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 61790-53-2: No information available.
Canada
CAS# 61790-53-2 is listed on Canada's NDSL List.
CAS# 61790-53-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 61790-53-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 6/03/1999 Revision #4 Date: 12/03/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
2-(Piperidylmethyl)-1-Cyclohexanone Hydrochloride, 98%
| 6966-09-2 |
|
Fluorosilicic Acid (25 Wt % Aqueous Solution)
| 7732-18-5 |
|
(S)-(-)-Bupivacaine hydrochloride, 99%
| 27262-48-2 |
|
6,7-Diethoxy-3,4-Dihydroisoquinoline-1(2H)-Thione, 98%
| 0-01-1 |
|
Sodium phosphate, dibasic anhydrous, reagent ACS
| 7558-79-4 |
|
1-Nonanol
| 143-08-8 |
|
2-Acetyl-6,7-Dimethoxy-1-Methylene-1,2,3,4-Tetrahydroisoquinoline,
| 57621-04-2 |
|
Lithium methoxide, 10% solution in methanol
| 865-34-9 |
|
[(3S)-4-Azabicyclo[4.4.0]Dec-3-yl]-N-(Tert-Butyl)Carboxamide, 99%
| 136465-81-1 |
|
C-Benzylcalix(4)resorcinarene
| 0-01-1 |
|
(S)-(-)-2-(2'-Carbomethoxyethyl)-2-Methyl-Cyclohexanone, 98.5+%
| 112898-44-9 |
|
(S)-(-)-alpha-Amino-gamma-butyrolactone hydrochloride, 98%
| 2185-03-7 |
|
N-Benzylmaleimide
| 1631-26-1 |
|
4-(Methylamino)benzoic acid, 97%
| 10541-83-0 |
|
Ethyl (3S)-3-Hydroxybutyrate, 99%
| 56816-01-4 |
|
Hydrofluoric Acid (48-51%), Reagent ACS
| 7664-39-3 |
|
ETHYL (1R,2S)-2-HYDROXYCYCLOHEXANECARBOXYLATE
| 61586-78-5 |
|
Iodic Acid, Reagent ACS (Crystals), 99.5% (Titr.)
| 7782-68-5 |
|
3-Pyrazolidinone Hydrochloride
| 1752-88-1 |
|
Tritylphenol
| 978-86-9 |
|
4-Hydroxy-2-Methoxybenzaldehyde, 98%
| 18278-34-7 |
|
4-Nitrobiphenyl, 98%
| 92-93-3 |
|
6-Iodo-2-picolin-5-ol, 97%
| 23003-30-7 |
|
Ethyl
| 100491-29-0 |
|
D(+)-Carnitine, 98%
| 541-14-0 |
|
D(+)-Carnitinenitrile Chloride, 97%
| 0-01-1 |
|
5-Amino-o-Cresol, 97%
| 2835-95-2 |
|
Hydrogen Peroxide (30% in Water) (Without Stabilizer), Reagent ACS
| 7722-84-1 |
|
4-Amino-o-Cresol, 97%
| 2635-95-2 |
|
Hydroquinone, p.a.
| 123-31-9 |
|
2,3-Difluoro-6-nitrophenol, 97%
| 82419-26-9 |
|
Hydroxylamine Sulfate, 99%
| 10039-54-0 |
|
Hypophosphorous Acid, 50 wt% Solution in Water
| 7732-18-5 |
|
cis-2-Heptene, 97%
| 6443-92-1 |
|
Imidazole
| 288-32-4 |
|
3-Amino-3-Cyclohexylpropionic Acid, 98%
| 129042-71-3 |
|
3-Fluorophenylacetic Acid, 98%(GC)
| 331-25-9 |
|
3-Benzylaminobutyric Acid, 98%
| 14676-01-8 |
|
4-NITROTHIOPHENOL, TECH., 80+%
| 1849-36-1 |
|
ALPHA,ALPHA-DIPHENYLGLYCINE, 98%
| 3060-50-2 |
|
Zirconium(IV) ethoxide, 99%
| 18267-08-8 |
|
Celite high-purity analytical grade
| 61790-53-2 |
|
2-CYANOETHYLHYDRAZINE, 98%
| 353-07-1 |
|
Pentamethylbenzaldehyde, 96%
| 17432-38-1 |
|
4-Chloro-3-nitrobenzenesulfonic acid, sodium salt, 98% (tlc)
| 17691-19-9 |
|
cis-2-Benzylaminomethyl-1-Cyclohexanol Hydrochloride, 98%
| 77612-17-0 |
|
Iron, electrolytically reduced, reagent (powder)
| 7439-89-6 |
|
1-(Gamma-Hydroxypropyl)-6,7-Dimethoxy-1,2,3,4-Tetrahydroisoquinoline
| 0-01-1 |
|
Iron (III) Oxide, 99.999%, -100 Mesh
| 1309-37-1 |
|
Perfluoroadipic acid hydrate, 98%
| 123334-02-1 |
|
|